Cargando…
Letter to the Editor: Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119553/ https://www.ncbi.nlm.nih.gov/pubmed/33565039 http://dx.doi.org/10.1007/s40122-020-00222-z |
| _version_ | 1783691879897890816 |
|---|---|
| author | Peckham, Alyssa M. Covvey, Jordan R. Evoy, Kirk E. |
| author_facet | Peckham, Alyssa M. Covvey, Jordan R. Evoy, Kirk E. |
| author_sort | Peckham, Alyssa M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8119553 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81195532021-05-14 Letter to the Editor: Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth” Peckham, Alyssa M. Covvey, Jordan R. Evoy, Kirk E. Pain Ther Letter Springer Healthcare 2021-02-09 2021-06 /pmc/articles/PMC8119553/ /pubmed/33565039 http://dx.doi.org/10.1007/s40122-020-00222-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Letter Peckham, Alyssa M. Covvey, Jordan R. Evoy, Kirk E. Letter to the Editor: Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth” |
| title | Letter to the Editor: Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth” |
| title_full | Letter to the Editor: Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth” |
| title_fullStr | Letter to the Editor: Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth” |
| title_full_unstemmed | Letter to the Editor: Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth” |
| title_short | Letter to the Editor: Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth” |
| title_sort | letter to the editor: comment on “gabapentinoid benefit and risk stratification: mechanisms over myth” |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119553/ https://www.ncbi.nlm.nih.gov/pubmed/33565039 http://dx.doi.org/10.1007/s40122-020-00222-z |
| work_keys_str_mv | AT peckhamalyssam lettertotheeditorcommentongabapentinoidbenefitandriskstratificationmechanismsovermyth AT covveyjordanr lettertotheeditorcommentongabapentinoidbenefitandriskstratificationmechanismsovermyth AT evoykirke lettertotheeditorcommentongabapentinoidbenefitandriskstratificationmechanismsovermyth |